These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 26973243

  • 1. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
    Zhai W, Sun Y, Jiang M, Wang M, Gasiewicz TA, Zheng J, Chang C.
    Oncogene; 2016 Sep 15; 35(37):4866-80. PubMed ID: 26973243
    [Abstract] [Full Text] [Related]

  • 2. Kidney cancer: AR promotes RCC via lncRNA interaction.
    Fenner A.
    Nat Rev Urol; 2016 May 15; 13(5):242. PubMed ID: 27041208
    [No Abstract] [Full Text] [Related]

  • 3. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
    Zhai W, Sun Y, Guo C, Hu G, Wang M, Zheng J, Lin W, Huang Q, Li G, Zheng J, Chang C.
    Cell Death Differ; 2017 Sep 15; 24(9):1502-1517. PubMed ID: 28644440
    [Abstract] [Full Text] [Related]

  • 4. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
    Chen Y, Sun Y, Rao Q, Xu H, Li L, Chang C.
    Oncotarget; 2015 Oct 13; 6(31):31203-15. PubMed ID: 26304926
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
    Zhai W, Sun Y, Jiang M, Wang M, Gasiewicz TA, Zheng J, Chang C.
    Oncogene; 2017 Aug 13; 36(31):4525. PubMed ID: 28368407
    [Abstract] [Full Text] [Related]

  • 6. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
    Petrella BL, Brinckerhoff CE.
    Cancer Biol Ther; 2009 Jul 13; 8(14):1389-401. PubMed ID: 19483472
    [Abstract] [Full Text] [Related]

  • 7. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 8. VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR.
    Liu C, Liu L, Wang K, Li XF, Ge LY, Ma RZ, Fan YD, Li LC, Liu ZF, Qiu M, Hao YC, Shi ZF, Xia CY, Strååt K, Huang Y, Ma LL, Xu D.
    Oncogene; 2020 May 16; 39(21):4286-4298. PubMed ID: 32291411
    [Abstract] [Full Text] [Related]

  • 9. Hypoxia-inducible factor-2alpha regulates the expression of TRAIL receptor DR5 in renal cancer cells.
    Mahajan S, Dammai V, Hsu T, Kraft AS.
    Carcinogenesis; 2008 Sep 16; 29(9):1734-41. PubMed ID: 18544564
    [Abstract] [Full Text] [Related]

  • 10. Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation.
    Greene CJ, Sharma NJ, Fiorica PN, Forrester E, Smith GJ, Gross KW, Kauffman EC.
    Free Radic Biol Med; 2019 Mar 16; 133():295-309. PubMed ID: 30553971
    [Abstract] [Full Text] [Related]

  • 11. Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer.
    Smith K, Gunaratnam L, Morley M, Franovic A, Mekhail K, Lee S.
    Cancer Res; 2005 Jun 15; 65(12):5221-30. PubMed ID: 15958567
    [Abstract] [Full Text] [Related]

  • 12. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.
    Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC.
    Cancer Cell; 2007 Apr 15; 11(4):335-47. PubMed ID: 17418410
    [Abstract] [Full Text] [Related]

  • 13. Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.
    Messai Y, Gad S, Noman MZ, Le Teuff G, Couve S, Janji B, Kammerer SF, Rioux-Leclerc N, Hasmim M, Ferlicot S, Baud V, Mejean A, Mole DR, Richard S, Eggermont AM, Albiges L, Mami-Chouaib F, Escudier B, Chouaib S.
    Eur Urol; 2016 Oct 15; 70(4):623-632. PubMed ID: 26707870
    [Abstract] [Full Text] [Related]

  • 14. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA, Ashcroft M.
    Cancer Res; 2006 Jun 15; 66(12):6264-70. PubMed ID: 16778202
    [Abstract] [Full Text] [Related]

  • 15. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
    Shinojima T, Oya M, Takayanagi A, Mizuno R, Shimizu N, Murai M.
    Carcinogenesis; 2007 Mar 15; 28(3):529-36. PubMed ID: 16920734
    [Abstract] [Full Text] [Related]

  • 16. Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner.
    Huang Q, Sun Y, Zhai W, Ma X, Shen D, Du S, You B, Niu Y, Huang CP, Zhang X, Chang C.
    Oncogene; 2020 Oct 15; 39(43):6677-6691. PubMed ID: 32943729
    [Abstract] [Full Text] [Related]

  • 17. Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α.
    Fan Y, Li H, Ma X, Gao Y, Bao X, Du Q, Ma M, Liu K, Yao Y, Huang Q, Zhang Y, Zhang X.
    Oncotarget; 2016 Apr 05; 7(14):18280-94. PubMed ID: 26943772
    [Abstract] [Full Text] [Related]

  • 18. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
    Gong K, Zhang N, Zhang K, Na Y.
    Int J Mol Med; 2010 Dec 05; 26(6):907-12. PubMed ID: 21042786
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Physapubescin selectively induces apoptosis in VHL-null renal cell carcinoma cells through down-regulation of HIF-2α and inhibits tumor growth.
    Chen L, Xia G, Qiu F, Wu C, Denmon AP, Zi X.
    Sci Rep; 2016 Sep 01; 6():32582. PubMed ID: 27581364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.